TUSHAR MISRA

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Alejandra Carvajal, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by TUSHAR MISRA:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mersana Therapeutics, Inc. SVP, Chief Manuf. Officer Restricted Stock Unit 41,667 $112,918 $2.71 15 Jan 2024 Direct
Mersana Therapeutics, Inc. SVP, Chief Manuf. Officer Common Stock 17,966 $48,688 $2.71 16 Jan 2024 Direct
Mersana Therapeutics, Inc. SVP, Chief Manuf. Officer Stock Option (Right to Buy) 187,500 15 Jan 2024 Direct

Insider Reports Filed by TUSHAR MISRA

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MRSN Mersana Therapeutics, Inc. 13 Jan 2024 7 -$9,097 4 SVP, Chief Manuf. Officer 17 Jan 2024, 17:21
MRSN Mersana Therapeutics, Inc. 05 Sep 2023 1 $0 4 SVP, Chief Manuf. Officer 07 Sep 2023, 18:53
MRSN Mersana Therapeutics, Inc. 16 Aug 2023 3 -$2,251 4 SVP, Chief Manuf. Officer 18 Aug 2023, 17:01
MRSN Mersana Therapeutics, Inc. 13 Jan 2023 5 -$2,629 4 SVP, CMO 18 Jan 2023, 19:18
MRSN Mersana Therapeutics, Inc. 16 Aug 2022 3 -$13,341 4 Chief Manufacturing Officer 18 Aug 2022, 16:40
MRSN Mersana Therapeutics, Inc. 14 Jan 2022 2 $0 4 Chief Manufacturing Officer 19 Jan 2022, 17:03
MRSN Mersana Therapeutics, Inc. 16 Aug 2021 2 $0 4 Chief Manufacturing Officer 18 Aug 2021, 16:32
MRSN Mersana Therapeutics, Inc. 16 Aug 2021 0 $0 3 Chief Manufacturing Officer 18 Aug 2021, 16:30